Pages that link to "Q40612791"
Jump to navigation
Jump to search
The following pages link to Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells (Q40612791):
Displaying 50 items.
- Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders (Q24532028) (← links)
- Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression (Q24630903) (← links)
- Evaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptors (Q24670461) (← links)
- Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands (Q27671769) (← links)
- Structural Characterization of Binding Mode of Smoking Cessation Drugs to Nicotinic Acetylcholine Receptors through Study of Ligand Complexes with Acetylcholine-binding Protein (Q27678875) (← links)
- From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research (Q28288721) (← links)
- Functional expression of human α9* nicotinic acetylcholine receptors in X. laevis oocytes is dependent on the α9 subunit 5' UTR. (Q30454356) (← links)
- Label-free measuring and mapping of binding kinetics of membrane proteins in single living cells (Q30539992) (← links)
- Mapping single-cell-substrate interactions by surface plasmon resonance microscopy (Q30540005) (← links)
- Extracellular domain nicotinic acetylcholine receptors formed by alpha4 and beta2 subunits (Q31005986) (← links)
- Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. (Q33738559) (← links)
- Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors (Q33954007) (← links)
- Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. (Q33955964) (← links)
- Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding (Q34082354) (← links)
- Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptors. (Q34127939) (← links)
- Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists. (Q34215376) (← links)
- Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats (Q34239996) (← links)
- The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile. (Q34286851) (← links)
- A component of Premarin® enhances multiple cognitive functions and influences nicotinic receptor expression (Q34316221) (← links)
- In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs (Q34387101) (← links)
- Human α4β2 nicotinic acetylcholine receptor as a novel target of oligomeric α-synuclein (Q34598256) (← links)
- Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine. (Q34961709) (← links)
- Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes. (Q35089573) (← links)
- Roles of nicotinic acetylcholine receptor β subunit cytoplasmic loops in acute desensitization and single-channel features (Q35132592) (← links)
- Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depression (Q35402036) (← links)
- Endogenously Expressed Muscarinic Receptors in HEK293 Cells Augment Up-regulation of Stably Expressed α4β2 Nicotinic Receptors (Q35562759) (← links)
- Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity (Q35738694) (← links)
- Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile (Q35799702) (← links)
- Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats (Q36186198) (← links)
- Nicotinic agonists, antagonists, and modulators from natural sources (Q36216398) (← links)
- Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. (Q36493695) (← links)
- Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity (Q36825487) (← links)
- Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies (Q36895981) (← links)
- Cyclic AMP-dependent protein kinase A and protein kinase C phosphorylate alpha4beta2 nicotinic receptor subunits at distinct stages of receptor formation and maturation (Q37148158) (← links)
- Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II. (Q37350898) (← links)
- N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes. (Q37361461) (← links)
- The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype (Q37405338) (← links)
- Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms (Q37508580) (← links)
- Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells (Q37728109) (← links)
- Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function (Q37728112) (← links)
- α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease (Q37952020) (← links)
- Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors (Q38126962) (← links)
- Cardiovascular effects of activation of central alpha7 and alpha4beta2 nAChRs: a role for vasopressin in anaesthetized rats (Q39517157) (← links)
- 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs (Q39942665) (← links)
- Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors (Q40009099) (← links)
- Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors (Q40258113) (← links)
- Kinetics of small molecule interactions with membrane proteins in single cells measured with mechanical amplification (Q42219351) (← links)
- Evaluation of the cardiovascular effects of varenicline in rats. (Q43200073) (← links)
- Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons (Q46220422) (← links)
- Influence of melatonin on the development of functional nicotinic acetylcholine receptors in cultured chick retinal cells (Q46552126) (← links)